Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 5

1.

ERRĪ² signalling through FST and BCAS2 inhibits cellular proliferation in breast cancer cells.

Sengupta D, Bhargava DK, Dixit A, Sahoo BS, Biswas S, Biswas G, Mishra SK.

Br J Cancer. 2014 Apr 15;110(8):2144-58. doi: 10.1038/bjc.2014.53. Epub 2014 Mar 25.

PMID:
24667650
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The transcriptional co-factor RIP140 regulates mammary gland development by promoting the generation of key mitogenic signals.

Nautiyal J, Steel JH, Mane MR, Oduwole O, Poliandri A, Alexi X, Wood N, Poutanen M, Zwart W, Stingl J, Parker MG.

Development. 2013 Mar;140(5):1079-89. doi: 10.1242/dev.085720.

PMID:
23404106
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

In Silico Prediction for Regulation of Transcription Factors onTheir Shared Target Genes Indicates Relevant Clinical Implications in a Breast Cancer Population.

Liu LY, Chang LY, Kuo WH, Hwa HL, Shyu MK, Chang KJ, Hsieh FJ.

Cancer Inform. 2012;11:113-37. doi: 10.4137/CIN.S8470. Epub 2012 Apr 19.

PMID:
22553415
[PubMed]
Free PMC Article
4.

ESRRA-C11orf20 is a recurrent gene fusion in serous ovarian carcinoma.

Salzman J, Marinelli RJ, Wang PL, Green AE, Nielsen JS, Nelson BH, Drescher CW, Brown PO.

PLoS Biol. 2011 Sep;9(9):e1001156. doi: 10.1371/journal.pbio.1001156. Epub 2011 Sep 20.

PMID:
21949640
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Putative biomarkers and targets of estrogen receptor negative human breast cancer.

Sahab ZJ, Man YG, Byers SW, Sang QX.

Int J Mol Sci. 2011;12(7):4504-21. doi: 10.3390/ijms12074504. Epub 2011 Jul 13.

PMID:
21845093
[PubMed - in process]
Free PMC Article

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk